|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：A112502 |
| 產(chǎn)品名稱：ABT 263-d8 |
| 產(chǎn)品CAS：1217620-38-6 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
A112502 |
| 名稱: |
ABT 263-d8 |
| 別名: |
4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide-d8; |
| CAS號(hào): |
1217620-38-6 |
| 備用CAS: |
未標(biāo)記: 923564-51-6 |
| 分子式: |
C??H??D?ClF?N?O?S? |
| 狀態(tài)： |
白色至淡黃色固體 |
| 熔點(diǎn)： |
>111°C (dec.) |
| 分子量: |
982.66 |
| 儲(chǔ)存： |
-20°C Freezer, Under Inert Atmosphere |
| 溶解性: |
Chloroform, DMSO |
| 類別: |
Standards; Chiral Molecules; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
A novel inhibitor of antiapoptotic BCL-2 proteins; a new promising anticancer drug candidate. |
| 參考: |
|
|
|
|
|
|
?您的位置：
